Pricing Log in Create free account

Equillium, Inc. (EQ) vs TuHURA Biosciences, Inc. (HURA)

Equillium, Inc. and TuHURA Biosciences, Inc. are both Biotechnology companies. Equillium, Inc. and TuHURA Biosciences, Inc. are of similar size ($96.2M and $92.3M). Across the 11 metrics below, Equillium, Inc. leads on 9 and TuHURA Biosciences, Inc. on 2.

Valuation

Metric EQ HURA Biotechnology median
P/E n/m n/m 11.58
P/S 3.86 n/m 9.61
P/B 2.83 5.30 2.26
Price to free cash flow n/m n/m 26.41
EV/EBITDA n/m n/m 0.72
EV/Sales 2.66 n/m 9.43
Earnings yield (14.08%) (35.76%) (32.28%)
Free cash flow yield (12.65%) (31.00%) (22.27%)

Profitability

Metric EQ HURA Biotechnology median
Gross margin 100.00% 0.00% 68.81%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (58.98%) (163.84%) (50.30%)
Return on assets (50.68%) (92.31%) (45.47%)
Return on invested capital 0.00% (74.20%) 0.00%

Growth

Metric EQ HURA Biotechnology median
Revenue growth (TTM) 13.89% — 6.78%
EPS growth (last fiscal year) (69.57%) 47.93% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric EQ HURA Biotechnology median
Debt to equity 0.00 0.47 0.00
Current ratio 23.40 0.18 4.74
Net debt to EBITDA 1.29 0.12 1.01

Dividend

Metric EQ HURA Biotechnology median
Dividend yield — — 0.39%
Payout ratio — — —

Size

Metric EQ HURA Biotechnology median
Market cap 92.26m 96.23m 168.63m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack